Tuesday, October 4, 2022


Biotechnology News Magazine

Parse Biosciences Announces Partnership with Molecular Diagnostics Korea

With products now available in South Korea, the partnership broadens access to single-cell genomics research in Asia.

Latest Posts

BRAINBox Solutions Announces New U.S. Patent Allowance, Strengthening Biomarker Portfolio for Multi-Modal Mild Traumatic Brain Injury Test

BRAINBox Solutions notes the new patent covers both diagnosis of TBI and patient monitoring post-injury, particularly for determining return to work or play.

New Initiative Brings Leading Life Sciences Companies Together To Drive Collective Impact in Awareness, Diagnosis, Care, and Health Equity for Patients with Amyloidosis

Despite notable progress in recent years, amyloidosis patients continue to experience high unmet needs and gaps in treatment and support.

GBS Inc. Acquires Intelligent Fingerprinting Limited and its Proprietary Drugs of Abuse Screening Technology

Steven Boyages, CEO of GBS Inc. stated, “We believe this acquisition generates significant value for our shareholders, and I am extremely excited to be on the forefront of this transition. Bringing IFP under the GBS umbrella marks a significant advancement toward achieving our strategic goals of improving patients’ lives outside of saliva-based glucose testing and laying the pathway in becoming a leader in the development of rapid, non-invasive diagnostic solutions. We remain excited to accelerate our strategy and revenue growth through this collaboration with IFP.”

Araris Biotech Closes $24 Million Financing Round

Araris Biotech notes the proceeds from the financing will be used to support the further development and advancement of Araris’ antibody-drug conjugate (ADC) candidates, created using the Company’s proprietary linker technology, as Araris moves closer toward clinical development.

Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular Diagnostics Korea (MDxK) that will expand its presence in Asia by providing its entire line of Evercode™ Whole Transcriptome products as well as Cell and Nuclei Fixation kits in South Korea.

MDxK provides instruments, consumables, and various services to support molecular research. The company’s specialization in areas of multi-omics, biologics, crystallography, and bio-banking has led to its status as a premier supplier of research tools with superior outcomes.

The partnership comes shortly after the announcement of Parse Biosciences’ $41.5M Series B round in February 2022, which is enabling the company to expand the commercialization of its single-cell RNA-Seq products in response to growing demand. It further provides distribution support for the expanding product portfolio, which includes applications in immune profiling, chromatin profiling, CRISPR screens, and targeted gene panels. The Parse Biosciences approach to single-cell sequencing is based on the Evercode technology, a patented technique of split-pool combinatorial barcoding that enables researchers to sequence cells at scale without the need for expensive lab equipment.

“We are working hard to bring simpler, more scalable, and affordable solutions to researchers, regardless of location,” said Alex Rosenberg, CEO and Co-founder of Parse Biosciences. “We are thrilled to partner with MDxK to broaden access to our technology and support the growing single-cell sequencing community worldwide.”

“We are very pleased to work with Parse Biosciences and proud of providing such advanced technology to the rapidly growing single-cell research field,” said MDxK CEO SungBo Shim. “We believe these scalable solutions give researchers broader and deeper biological insight with more cost effectiveness.”

Access to the Parse Biosciences technology has grown rapidly since the commercial availability of its products in 2021. Since expanding beyond North America to Europe, Australia, New Zealand, and Southeast Asia, Parse is now used in over 300 labs across the globe.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine